Return to CBI Antibody Core Home Page
  Return to biothreat/emerging pathogens list
    Return to Campylobacteriosis (C. jejuni) ( Campylobacter jejuni ) list


Campylobacteriosis (C. jejuni) ( Campylobacter jejuni )
cj1190c


Links to multiple antibodies on this page for cj1190c:
cetA
cetA


Western result: +
GST
GST-cetA
A1172a
(fragment)

25 kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (GST-antigen fusion protein). The negative control lane is the same except it contains ~50ng to 100 ng of a GST fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used and it is fused to GST.

Antibody Name/Abbreviation: cetA
CBI Antibody Core Code: A1172a

"Lot" Number: 1 Position: 100 (355-454)
% Identical Homology of Target to Mouse Protein: 34% (XP_146948.4| unc13 homolog 3)
Molecular Weight of fusion protein: 25 KDa

Target sequence used to make this antibody:
SVVKIDHILYKSNIYLNLNGAQNFNLESVDPISNLCQDER
AQGVINELSSETELNLAKEFIKDNAKKAIEESSQDYIDQK
AYDAIVNDIKSLEQRSAEIL






Antibody Name/Abbreviation: cetA
CBI Antibody Core Code: A1172b

"Lot" Number: 1 Position: 20 (161-180)
% Identical Homology of Target to Mouse Protein: 0%
Molecular Weight of fusion protein: 32.2 KDa

Target sequence used to make this antibody:
LSLGNQNKDMSQISSSLNQD






Sequence Name: cj1190c
Full name:
UniGene Number: N.A.
Accession Number: N.A.
Source organism: Campylobacteriosis (C. jejuni) ( Campylobacter jejuni )
Full length size (aa): 459
NCBI information page:

Full length sequence:
MVKNGLLLTIFLSVIGVLGVIFIHIFVGAIIFVLIAVLMIYLLRQHKDEQ
IMIDKLLVLCRELKEGNFDNRIIYVKTKSKKLAEIADNLNNTIDGLEAYL
REINTSISCSQKGEFYRKALPEGLKGIFAHNIEFINKALANIEVTARSTF
KNALSRTLMDLSLGNQNKDMSQISSSLNQDISMMKNVYDTVDAISHTATE
NGSEVDSLQSAMGSLMDVVNSSKETVQTFVANSQNITSVVEVIRDIADQT
NLLALNAAIEAARAGEHGRGFAVVADEVRKLAERTQRSTSEISIAIQTMQ
QDFVNIQSGSEQVFNIVSESEERINKFSQAFKRLEENSSALGVNFGSFAK
RLILSVVKIDHILYKSNIYLNLNGAQNFNLESVDPISNLCQDERAQGVIN
ELSSETELNLAKEFIKDNAKKAIEESSQDYIDQKAYDAIVNDIKSLEQRS
AEILAKLKI





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.